Lack of effects of low-dose aspirin on high sensitivity C-reactive protein, hemostatic factors, and troponin T in CAPD patients

Peritoneal Dialysis International

Volumn 22, Issue 6, 2002, Pages 721-723

  Kim, Soon Bae ^b   Lee, Sang Koo ^b   Min, Won Ki ^a   Chi, Hyun Sook ^a   Park, Jung Sik ^b  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; INTERLEUKIN 6; TROPONIN I; TROPONIN T; VON WILLEBRAND FACTOR;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART PROTECTION; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; STABLE ANGINA PECTORIS;

EID: 4444274261     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200613     Document Type: Article

References (7)

1. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906.
2. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100:793-8.
3. Pernerstorfer T, Eichler HG, Stohlawetz P, Speiser W, Jilma B. Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand factor levels in healthy men. Atherosclerosis 2001; 155:389-93.
4. de Winter RJ. C-Reactive protein and cardiac troponin for early risk stratification in patients with acute coronary syndromes. Clin Chim Acta 2001; 311:53-6.
5. Kennon S, Price CP, Mills PG, Ranjadayalan K, Cooper J, Clarke H, et al. The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol 2001; 37:1266-70.
6. Feng D, Tracy RP, Lipinska I, Murillo J, McKenna C, Tofler GH. Effect of short-term aspirin use on C-reactive protein. J Thromb Thrombolysis 2000; 9:37-41.
7. Feldman M, Jialal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001; 37:2036-41.